Cargando…
FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance
Estrogen receptor-α (ERα) mediates the essential biological function of estrogen in breast development and tumorigenesis. Multiple mechanisms, including pioneer factors, coregulators, and epigenetic modifications have been identified as regulators of ERα signaling in breast cancer. However, previous...
Autores principales: | Yu-Rice, Yi, Jin, Yanli, Han, Bingchen, Qu, Ying, Johnson, Jeffrey, Watanabe, Takaaki, Cheng, Long, Deng, Nan, Tanaka, Hisashi, Gao, Bowen, Liu, Zhenqiu, Sun, Zhijun, Bose, Shikha, Giuliano, Armando E., Cui, Xiaojiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287293/ https://www.ncbi.nlm.nih.gov/pubmed/27041579 http://dx.doi.org/10.1038/onc.2016.78 |
Ejemplares similares
-
Inhibition of lobuloalveolar development by FOXC1 overexpression in the mouse mammary gland
por: Gao, Bowen, et al.
Publicado: (2017) -
Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer
por: Chung, Stacey, et al.
Publicado: (2017) -
FOXC1: an emerging marker and therapeutic target for cancer
por: Han, Bingchen, et al.
Publicado: (2017) -
FOXC1-Induced Non-Canonical WNT5A-MMP7 Signaling Regulates Invasiveness in Triple-Negative Breast Cancer
por: Han, Bingchen, et al.
Publicado: (2017) -
FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort
por: Johnson, Jeff, et al.
Publicado: (2016)